SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wasserman Chad J

(Last)

(First)

(Middle)

ONE PARK PLAZA

(Street)

NASHVILLE

37203

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/01/2024

3. Issuer Name and Ticker or Trading Symbol
HCA Healthcare, Inc. [ HCA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP and CIO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	942.3102⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	⁽²⁾	02/03/2031	Common Stock	255	⁽³⁾	D
Restricted Stock Units	⁽⁴⁾	01/28/2032	Common Stock	170	⁽³⁾	D
Restricted Stock Units	⁽⁵⁾	01/30/2033	Common Stock	449	⁽³⁾	D
Stock Appreciation Right	⁽⁶⁾	01/31/2028	Common Stock	6,290	$101.16	D
Stock Appreciation Right	⁽⁷⁾	01/30/2029	Common Stock	3,670	$139.06	D
Stock Appreciation Right	⁽⁸⁾	01/29/2030	Common Stock	1,320	$145.24	D
Stock Appreciation Right	⁽⁹⁾	02/03/2031	Common Stock	850	$173.12	D
Stock Appreciation Right	⁽¹⁰⁾	01/28/2032	Common Stock	565	$236.61	D
Stock Appreciation Right	⁽¹¹⁾	01/30/2033	Common Stock	1,350	$253.3	D
Stock Appreciation Right	⁽¹²⁾	01/31/2034	Common Stock	8,255	$304.9	D

Explanation of Responses:

1. Includes 35.3102 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

2. The restricted stock units vest in two equal annual installments beginning on February 3, 2024.

3. Each restricted stock unit represents a contingent right to receive one share of HCA Healthcare, Inc. common stock.

4. The restricted stock units vest in two equal annual installments beginning on January 28, 2025.

5. The restricted stock units vest in three equal annual installments beginning on January 30, 2025.

6. The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

7. The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.

8. The stock appreciation rights vested in four equal annual installments beginning on January 29, 2021.

9. The stock appreciation rights vest in two equal annual installments beginning on February 3, 2024.

10. The stock appreciation rights vest in two equal annual installments beginning on January 28, 2025.

11. The stock appreciation rights vest in three equal annual installments beginning on January 30, 2025.

12. The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025.

Remarks:

	/s/ Kevin A. Ball, Attorney-in-Fact	02/06/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.